Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs VICI Properties Inc (VICI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs VICI Properties Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while VICI Properties Inc trades at $22.88 (market cap $25.09B). The key difference: VICI Properties Inc is the larger of the two by market cap, and VICI Properties Inc pays a 8.07% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and VICI Properties Inc for 43 Days on average.
| HALO | VICI | |
|---|---|---|
Market Cap | $12.58B | $25.09B |
Volume | 2,179,278 | 17,066,337 |
Sector | Health | Real Estate |
52-Week High | $115.22 | $31.42 |
52-Week Low | $61.63 | $22.53 |
Typical Hold Time | 1 Days | 43 Days |
Enterprise Value | $14.49B | $42.65B |
Dividend Yield | — | 8.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VICI Properties trades at $22.88, down 1.04% recently but showing mixed technical signals with bearish moving averages against neutral oscillators. The REIT maintains strong fundamentals with 67.5% net income margins and trades at attractive valuations including a P/E of 8.83 and P/B of 0.86. Recent developments include new tenant leases and a dividend increase to $0.46, though earnings have been inconsistent with two misses in the last three quarters.
The stock presents a compelling value opportunity with significant upside to the $28.90 consensus target, supported by strong cash flow generation and dividend coverage. However, risks include tenant concentration concerns with Caesars and MGM, rising interest rate sensitivity, and recent earnings volatility that could pressure the premium valuation multiple.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About VICI Properties Inc
VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →
